APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

BACKGROUND: The APOE genotype predicts the age at onset of Alzheimer disease (AD) and neuropathologic progression. However, studies relating APOE alleles to the rate of cognitive decline have been inconclusive. This may stem from their use of linear statistical analyses. OBJECTIVE: To model relation...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Martins, C, Oulhaj, A, de Jager, C, Williams, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2005

Míreanna comhchosúla

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
de réir: Oulhaj, A, et al.
Foilsithe / Cruthaithe: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
de réir: Oulhaj, A, et al.
Foilsithe / Cruthaithe: (2010)

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele
de réir: Marian Shahid, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
de réir: Haixu Ma, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
de réir: Laura B Zahodne, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
de réir: B.V.P. de-Almada, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
de réir: Kazushi Suzuki, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
de réir: B.V.P. de-Almada, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
de réir: Oulhaj, A, et al.
Foilsithe / Cruthaithe: (2016)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
de réir: Holmes, C, et al.
Foilsithe / Cruthaithe: (2005)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
de réir: Jori Tomassen, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
de réir: Coralie Barbe, et al.
Foilsithe / Cruthaithe: (2016-12-01)

Periodontitis and Cognitive Decline in Alzheimer's Disease.
de réir: Mark Ide, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease
de réir: Céline H. De Jager, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
de réir: Allen, G, et al.
Foilsithe / Cruthaithe: (2016)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
de réir: I. K. Malashenkova, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
de réir: Pia Kivisäkk, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
de réir: Hákon Valur Dansson, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
de réir: Lai, M, et al.
Foilsithe / Cruthaithe: (2002)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
de réir: Nicholas C. Cullen, et al.
Foilsithe / Cruthaithe: (2021-06-01)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
de réir: Lai, M, et al.
Foilsithe / Cruthaithe: (2006)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
de réir: Lai, M, et al.
Foilsithe / Cruthaithe: (2006)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
de réir: Selma M. Soyal, et al.
Foilsithe / Cruthaithe: (2020-08-01)

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment
de réir: Mana Shams, et al.
Foilsithe / Cruthaithe: (2022-07-01)

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
de réir: Sungyang Jo, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
de réir: Yury Loika, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Rates of decline in Alzheimer disease decrease with age.
de réir: Dominic Holland, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Predicting cognitive decline in healthy older adults.
de réir: De Jager, C, et al.
Foilsithe / Cruthaithe: (2005)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
de réir: Belbin, O, et al.
Foilsithe / Cruthaithe: (2009)

Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample
de réir: Xiaoran Liu, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Effect of APOE and CD33 on Cognitive Decline.
de réir: Kathleen M Hayden, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
de réir: Heather E. Dark, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
de réir: Joseph Giorgio, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease
de réir: Mitchell K.P. Lai, et al.
Foilsithe / Cruthaithe: (2006-06-01)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
de réir: Taizen Nakase, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
de réir: Jagan A. Pillai, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
de réir: Corinna M. Bauer, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
de réir: Florian U. Fischer, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
de réir: Jagan A. Pillai, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Correction: Effect of APOE and CD33 on Cognitive Decline.
de réir: Kathleen M Hayden, et al.
Foilsithe / Cruthaithe: (2015-01-01)